Eculizumab Therapy in Neuromyelitis Optica Spectrum Disorders

This chapter explores the application of eculizumab, a complement inhibitor, in addressing Neuromyelitis Optica Spectrum Disorders. It emphasizes the drug's mechanism, potential side effects, and the critical need for vaccination and antibiotic measures before treatment.